Position in GILD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$17,125,003
-$3,401,824 QoQ
Shares Held
135,547
-8.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#347
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEEDER ASSET MANAGEMENT INC holds $140,500,918 across 9 Drug Manufacturers - General names. GILD ranks #5 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,922 | $34,689,912 | |
| 2 | JNJ |
Johnson & Johnson
|
117,192 | $29,763,248 | |
| 3 | ABBV |
AbbVie Inc.
|
98,512 | $24,789,557 | |
| 4 | AMGN |
Amgen Inc
|
65,451 | $23,701,113 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
135,547 | $17,125,003 | |
| 6 | MRK |
Merck & Co., Inc.
|
71,755 | $9,220,516 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
20,426 | $1,176,942 | |
| 8 | PFE |
Pfizer Inc
|
1,115 | $26,849 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,125,003 | 135,547 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $20,526,827 | 147,283 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $18,526,372 | 150,940 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $16,754,895 | 150,945 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $18,634,361 | 168,074 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $18,827,421 | 168,027 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $19,823,153 | 214,606 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $15,932,530 | 190,035 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $10,126,218 | 147,591 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $5,516,310 | 75,308 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $7,615,911 | 94,012 | Shares | Sole | 2024-01-25 | |
| 2023-06-30 | $7,350,627 | 95,376 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,696,459 | 92,762 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,932,365 | 92,398 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,343,575 | 119,040 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,886,372 | 111,412 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $6,438,371 | 108,299 | Shares | Defined | 2022-05-10 | |
| 2021-09-30 | $6,141,906 | 87,930 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $5,899,580 | 85,675 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $5,511,772 | 85,282 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $712,752 | 12,234 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $5,173,992 | 81,880 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $6,502,119 | 84,509 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $8,868,701 | 118,629 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||